Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk.
about
Lipoprotein(a) as a cardiovascular risk factor: current statusLipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biologyEpidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario.Lipoprotein (a), an independent cardiovascular risk markerLipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy.Lipoprotein(a): an emerging cardiovascular risk factor.Influence of smoking on predictors of vascular disease.Lipoprotein(a): an elusive cardiovascular risk factorLipoprotein(a): biology and clinical importanceEffects of oestrogen receptor-active compounds on lipid metabolism.Lipoprotein (A): Better assessor of coronary heart disease risk in south Indian populationLipoprotein(a) and SYNTAX Score Association with Severity of Coronary Artery Atherosclerosis in North India.Lipoprotein (a) measurements for clinical application.Lipoprotein (a) Levels in Relation to Severity of Coronary Artery Disease in North Indian Patients.Lipoprotein(a) Interactions With Low-Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS).The role of advanced lipid testing in clinical practice.The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.Metabolic syndrome and cardiovascular disease in South Asians.Lipoprotein(a) is not related to markers of insulin resistance in pregnancy.Relationship between Lipoprotein(a) and Thyroid Hormones in Hypothyroid Patients.Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines.Levels of Apolipoprotein A1, B100 and Lipoprotein (a) in Controlled and Uncontrolled Diabetic Patients and in Non-Diabetic Healthy People.Lipoprotein(a) and LDL particle size are related to the severity of coronary artery disease.Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a).Lipoprotein(a) as a cardiovascular risk factor.Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolismLp(a) and risk of recurrent cardiac events in obese postinfarction patients.Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy.Relevance of post-methionine homocysteine and lipoprotein (a) in evaluating the cardiovascular risk in young CAD patients.High-density lipoprotein subclass distribution in individuals of Asian Indian descent: the National Asian Indian Heart Disease Project.Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease.Management of cardiovascular risk factors in patients with ANCA-associated vasculitis.[Lipoprotein(a): influence on cardiovascular manifestation].Will you, nill you, I will treat you: the taming of lipoprotein(a).Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease
P2860
Q24623225-5C9ADC5B-B2BD-4ECD-A0FF-FE71FC000F4BQ30242031-89F0EAB8-922A-488F-8DFA-B411B60AC49AQ33674543-15618D4D-3128-40BF-8A38-23806CBB9F3CQ33801207-C9BAE1C2-0F0F-4E6C-AC95-1C68EFDA9372Q34116379-867708D3-C961-49F1-8F68-2ACE16380A39Q35081894-98ADB42F-BD05-469C-A93C-3A1A8A625553Q35562469-044E6A49-E7D3-4AA8-B47E-266B7993E28FQ35746190-7B9FCD15-9527-43C5-AE65-3E9D42E19847Q35754367-D4840B3C-032B-4323-8E05-1B75F4993D89Q36210997-693A77B8-4F13-4E47-96DB-D233A1E2F1C1Q36265876-1C6F9D32-46C7-4FFE-952F-609D5B91D6BDQ36471771-70CBE796-497A-4FC4-B2D7-C4143E97A361Q36731801-893F30B6-D7DB-4112-9D0B-CF651E9063F8Q36752405-EB48BF88-B797-4F99-907C-8527247628F3Q36877240-9E93F1AA-87C7-4B7E-B53D-538D389534BEQ36961412-B194269B-759B-4C9E-AFD7-E9A822E163A7Q37311116-C2629F10-2535-4BF7-B298-87219313735CQ37343671-C74D4C27-C418-4DA6-B38D-AA2A7AA5E868Q37362217-CEE3A615-3815-4F00-B2CC-0C92C2859382Q37679079-CB292645-9A6A-49AA-9BB7-A4829FAEAE33Q37703242-2868BD10-8387-42FD-94D5-26F079A53C0AQ37734181-936BA53C-8D13-4616-803F-3C265908F7A3Q38507044-456BBBAB-37F1-4B9F-954E-9454A6A4CB22Q39148923-70CB0585-1359-463B-B21F-0130371C6FA8Q40409855-17666A8E-E446-4B5C-B690-76DB2EB141F1Q42156986-3C1A360F-C3F3-4FAF-BFC7-861553C0B288Q43660736-1BE5841B-E356-4DF6-ACDE-0A2CC2A32A22Q44622602-F9F737C9-0A4C-46F6-B4C6-7A839C03A279Q45215863-EF529618-E43B-4687-BE59-83A78FCD6F1CQ46463284-1BDA2237-3124-4498-81BD-57FD6642247EQ46504299-7D599B0F-25E0-48AA-931F-077502FB759AQ48230398-C42AD072-857E-4816-B26B-369DFA6737A7Q53614132-D9C2CF7F-3A8C-4293-82F5-26F8E644A2BFQ54737669-344A06A8-E363-4206-A63C-FA653D2B6712Q57193293-A232B29A-2C3D-4978-BD71-3BC9D84E0173
P2860
Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Lipoprotein(a) further increas ...... gh global cardiovascular risk.
@ast
Lipoprotein(a) further increas ...... gh global cardiovascular risk.
@en
type
label
Lipoprotein(a) further increas ...... gh global cardiovascular risk.
@ast
Lipoprotein(a) further increas ...... gh global cardiovascular risk.
@en
prefLabel
Lipoprotein(a) further increas ...... gh global cardiovascular risk.
@ast
Lipoprotein(a) further increas ...... gh global cardiovascular risk.
@en
P2093
P921
P1476
Lipoprotein(a) further increas ...... gh global cardiovascular risk.
@en
P2093
von Eckardstein A
P304
P356
10.1016/S0735-1097(00)01126-8
P407
P577
2001-02-01T00:00:00Z